Evoke Pharma (EVOK) News Today → Special FREE offer on stock hotsheets (From DTI) (Ad) Free EVOK Stock Alerts $0.48 +0.04 (+9.20%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | americanbankingnews.comEvoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.comMay 16, 2024 | globenewswire.comEvoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) ConferenceMay 15, 2024 | finanznachrichten.deEvoke Pharma, Inc.: Evoke Pharma Reports First Quarter 2024 Financial ResultsMay 14, 2024 | msn.comEVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | globenewswire.comEvoke Pharma Reports First Quarter 2024 Financial ResultsMay 11, 2024 | msn.comOprah apologises for being 'major contributor' to diet culture after weight loss drugs admissionApril 26, 2024 | finance.yahoo.comEvoke Pharma, Inc. (EVOK)April 17, 2024 | finance.yahoo.comEvoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 MedicationsApril 17, 2024 | globenewswire.comEvoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 MedicationsApril 10, 2024 | finanznachrichten.deDelveInsight Business Research, LLP: Gastroparesis Market to Witness Upsurge in Growth at a CAGR of 7% by 2034 | DelveInsightApril 10, 2024 | msn.comEmpowering students: Innovative approaches to climate change educationApril 10, 2024 | finance.yahoo.comStephanie Carman Joins Underscore Marketing as SVP Client Services; Tiffany Marg Joins Strategy TeamApril 1, 2024 | msn.comHow a Dubai man built a $200,000 art collection in his Business Bay homeMarch 30, 2024 | msn.comThe Secret Behind Your Soda: The Cocaine-Free Journey of Coca Leaves in Coca-ColaMarch 30, 2024 | msn.comBrain-Triggered Snacking: A New Understanding of Eating Impulses : ScienceAlertMarch 22, 2024 | finanznachrichten.deEvoke Pharma, Inc.: Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive OfficerMarch 21, 2024 | marketwatch.comEvoke Pharma Taps Operating Chief D'Onofrio to Succeed CEO GonyerMarch 21, 2024 | finance.yahoo.comEvoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive OfficerMarch 21, 2024 | globenewswire.comEvoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive OfficerMarch 18, 2024 | msn.comBig change is the only constant in eco: India IncMarch 17, 2024 | seekingalpha.comEvoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | finance.yahoo.comEvoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?March 15, 2024 | msn.comBrain gain: Hope rises with new dementia treatmentsMarch 15, 2024 | finance.yahoo.comEvoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finanznachrichten.deEvoke Pharma, Inc.: Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 15, 2024 | msn.comEVOK Stock Earnings: Evoke Pharma Misses EPS, Beats Revenue for Q4 2023March 14, 2024 | msn.com‘Would have torn Modi into pieces’: DMK minister TM Anbarasan booked for remarks against PMMarch 14, 2024 | globenewswire.comEvoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 13, 2024 | benzinga.comA Preview Of Evoke Pharma's EarningsMarch 13, 2024 | markets.businessinsider.comEvoke Pharma Inc Registered Shs hosts conference call for investorsMarch 7, 2024 | globenewswire.comEvoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024February 27, 2024 | investing.comEvoke Pharma Inc (EVOK)February 26, 2024 | msn.comConfronting the legacy of the Holocaust in 2024 film ‘Treasure’ - reviewFebruary 26, 2024 | finance.yahoo.comEVOKE PHARMA INC.DL-,0001 (EV00.DU)February 24, 2024 | benzinga.comEvoke Pharma Stock (NASDAQ:EVOK) Dividends: History, Yield and DatesFebruary 22, 2024 | finance.yahoo.comLift Off with Spring Sculpture Exhibitions at Frederik Meijer Gardens & Sculpture ParkFebruary 15, 2024 | money.usnews.comEvoke Pharma IncFebruary 14, 2024 | finance.yahoo.comEvoke Pharma Announces Closing of $7.5 Million Public OfferingFebruary 14, 2024 | globenewswire.comEvoke Pharma Announces Closing of $7.5 Million Public OfferingFebruary 10, 2024 | markets.businessinsider.comEvoke Pharma Announces Pricing of Recent OfferingFebruary 10, 2024 | msn.comEvoke Pharma Strikes Deal to Offer Stocks and WarrantsFebruary 9, 2024 | markets.businessinsider.comEvoke Pharma Prices Public Offering Of Up To $30 Mln Of SharesFebruary 9, 2024 | finance.yahoo.comEvoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 MillionFebruary 5, 2024 | finance.yahoo.comMBX Biosciences Appoints Steven Ryder, M.D., to Board of DirectorsFebruary 4, 2024 | msn.comColumn: How Kamala Harris found her groove. And why being vice president is still toughFebruary 4, 2024 | msn.comHow Kamala Harris found her groove. And why being vice president is still toughFebruary 1, 2024 | finance.yahoo.comMBX Biosciences to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceJanuary 30, 2024 | finance.yahoo.comBen Beckley Joins RevHealth As CEOJanuary 29, 2024 | msn.comNectar Wellness Is Introducing Science into Your CBD and Cannabis ProductsJanuary 24, 2024 | markets.businessinsider.comAstraZeneca’s Market Position Strengthened by Rival Drug Trial Setback; Buy Rating Affirmed Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address 🚀 Tap into this explosive trade opportunity asap (Ad)I learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”… Go here to see how you can exploit my next “Calendar Stock”. EVOK Media Mentions By Week EVOK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVOK News Sentiment▼0.400.76▲Average Medical News Sentiment EVOK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVOK Articles This Week▼31▲EVOK Articles Average Week Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KPRX News IMNN News EDSA News HUGE News PIRS News RDHL News AVTX News MIRA News ELAB News RNAZ News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVOK) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss Ratings[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.